Internal Medicine, Endocrinology, Diabetes, & Metabolism · Rocky Mount, NC
NPI
1336157122
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
901 N Winstead Ave
Rocky Mount, NC, 27804
Phone (252) 937-0290
Groups this clinician bills Medicare through
Medicare paid, 2024
$203K
7,935 services
Medicare patients, 2024
753
Average age 74
Drug cost, 2024
$3.0M
6,890 prescriptions
Company payments, 2025
$44K
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nilay Desai was code J0897 (injection, denosumab, 1 mg), 3,720 times for 41 patients. In total Nilay Desai billed 7,935 services in 36 codes, and Medicare paid $203K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-03-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 3,720 | 41 | $20.33 | $76K |
| 99214 Office E&M - Established | Office | 848 | 600 | $80.16 | $68K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 521 | 416 | $11.46 | $5,973 |
| G0109 Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes | Office | 382 | 32 | $11.58 | $4,422 |
| G0108 Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 281 | 118 | $40.31 | $11K |
| 95251 Test - Miscellaneous | Office | 252 | 153 | $23.22 | $5,851 |
| 96372 Injection Administration | Office | 84 | 50 | $10.62 | $892 |
| 76536 Ultrasound - Nonspecific | Office | 70 | 69 | $44.70 | $3,129 |
| 99204 Office E&M - New | Office | 64 | 64 | $101.57 | $6,501 |
| 77080 Standard X-ray | Office | 49 | 49 | $26.71 | $1,309 |
| 36415 Venipuncture Blood Collection | Office | 43 | 32 | $8.65 | $372 |
| 72080 X-ray - Spine and Pelvis | Office | 27 | 27 | $14.74 | $398 |
| 99213 Office E&M - Established | Office | 20 | 18 | $41.60 | $832 |
| G0008 Administration of influenza virus vaccine | Office | 19 | 18 | $27.37 | $520 |
| 90662 Vaccine Product | Office | 16 | 16 | $76.71 | $1,227 |
By year: 2022 $219K for 8,294 services; 2023 $230K for 11,622 services; 2024 $203K for 7,935 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 43 | 32 | $8.65 | $372 |
Medicare prescription drug claims, 2024
In 2024, the drug Nilay Desai prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,069 prescriptions and refills. In total Nilay Desai wrote 6,890 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,069 | 2,544 | 299 | $11K |
| Metformin Hcl Er Metformin Hcl | 532 | 1,163 | 180 | $5,522 |
| Ozempic Semaglutide | 465 | 752 | 146 | $723K |
| Pioglitazone Hcl Generic | 299 | 665 | 102 | $3,102 |
| Nateglinide Generic | 287 | 657 | 126 | $15K |
| Jardiance Empagliflozin | 250 | 431 | 70 | $256K |
| Tresiba Flextouch U-200 Insulin Degludec | 208 | 448 | 75 | $197K |
| Glipizide Generic | 188 | 445 | 72 | $2,185 |
| Synthroid Levothyroxine Sodium | 175 | 423 | 47 | $17K |
| Methimazole Generic | 152 | 340 | 48 | $1,428 |
| Gvoke Hypopen 2-Pack Glucagon | 144 | 147 | 99 | $90K |
| Alendronate Sodium Generic | 137 | 334 | 36 | $1,045 |
| Metformin Hcl Generic | 136 | 339 | 51 | $1,018 |
| Tradjenta Linagliptin | 126 | 216 | 42 | $109K |
| Trulicity Dulaglutide | 121 | 178 | 39 | $176K |
Brand drugs: 3,532 claims; generic drugs: 3,002 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nilay Desai $44K ($44K in general payments such as food, travel and fees) from 6 companies. The largest payer was Novo Nordisk Inc with $35K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.